Columbia Sportswear Company

▲ Bull Case

• ◆Operating leverage inflection: Columbia's cost structure is ~60% fixed. Every +$100M of revenue produces ~$45–50M of incremental operating income. If ACCELERATE delivers +3–4% U.S. growth from FY2026–FY2028, operating margin recovers to 10–12% and EPS reaches $6–$8 vs. current $3.24 (85–147% earnings uplift).
• ◆Balance sheet fortress creates asymmetric floor: $791M in cash + investments (23% of market cap) and zero financial debt provides hard downside protection. Buyback program reduces shares ~6%/year, delivering 21% per-share uplift by FY2030E independent of earnings recovery.
• ◆International momentum validates global brand health: LAAP +10% CC and EMEA +10% CC in FY2025 demonstrate the Columbia brand functions well globally. A brand in secular decline does not produce 10% CC international growth; the U.S. problem is market-specific and addressable.

▼ Bear Case

• ◆SG&A deleverage is structural, not cyclical: Despite $150M+ in PIP savings, operating margins improved only ~10 bps from FY2024 to FY2025 because flat revenue prevents fixed-cost absorption. If U.S. revenue cannot recover, the company remains trapped at 6–8% operating margins permanently.
• ◆Brand cultural relevance is slipping: SOREL's -29%/-7% revenue decline reflects genuine consumer preference shift toward UGG, Blundstone, and fashion alternatives. The same dynamic—aspirational outdoor brands winning over value functional brands—could extend to Columbia's core brand with younger consumers.
• ◆Family control removes escape valves: The Boyle family's voting control eliminates typical shareholder value mechanisms (activist pressure, strategic M&A, leveraged recap, brand divestiture). No enforcement mechanism exists if ACCELERATE fails and margins deteriorate toward 5–6% permanently.

“The consensus (2 Buy / 6 Hold / 1 Sell; avg. target ~$62.60) centers on one question: Is Columbia's operating margin compression of FY2021–FY2025 (14.4% → 6.1%) cyclical or structural? Bulls argue trough-cycle value with ~60–70% cyclical compression; PIP savings + revenue recovery = $5–7 EPS by FY2028. Bears warn of deteriorating brand relevance and permanent SG&A deleverage. Holders acknowledge the value argument but need evidence of U.S. brand recovery before assigning a recovery multiple. Key resolution: Q3 2026 U.S. revenue (first full fall season under ACCELERATE; reported November 2026).”

• ◆Q3 2026 U.S. revenue inflection — first full back-to-school/fall season under ACCELERATE; threshold: U.S. YoY ≥ 0%
• ◆FY2026 operating margin delivery vs. guidance (6.7–7.5%); threshold: ≥7.3% demonstrates PIP savings converting to income
• ◆Trade policy normalization — July 2026 universal tariff review; any reduction in Vietnam tariff flows to gross margin
• ◆SOREL stabilization — any quarter with SOREL revenue flat-to-positive removes key bear-case pillar
• ◆Accelerated buyback — if management increases pace to $250–300M at current prices, signals conviction in intrinsic value

• ◆U.S. brand relevance further declines: U.S. revenue falls -3%+ in Q3 2026 post-ACCELERATE (HIGH probability, HIGH impact)
• ◆Tariff escalation: Vietnam IEEPA tariffs extend beyond July 2026 at full rates; gross margin compressed 300+ bps (MEDIUM-HIGH probability, HIGH impact)
• ◆FY2026 guidance miss: EPS guidance cut below $3.55 floor signals PIP is not converting (MEDIUM probability, HIGH impact)
• ◆SOREL brand impairment: $30–50M noncash charge; signal that portfolio deterioration is broadening (MEDIUM probability, MEDIUM impact)
• ◆Large M&A (>$500M): Would consume balance sheet fortress; poor historical M&A track record (LOW probability, HIGH impact)
• ◆Succession risk: Tim Boyle (76) departure before Joseph Boyle established; governance uncertainty during critical execution (LOW probability, HIGH impact)